An overview of colorectal cancer screening.
Colorectal cancer ranks highly amongst all cancer sites in incidence and contributes to a substantial number of cancer related deaths in the United Kingdom. However, screening of average risk individuals has been shown to reduce both disease associated mortality and incidence. This paper provides an overview of both current and future screening methods for colorectal cancer, as well as current practice for screening in both average and high risk individuals.
Goodbrand
S A
SA
Department of Surgery and Molecular Oncology, Ninewells Hospital and Medical School, Dundee, DD1 9SY. sarahgoodbrand@nhs.net
Steele
R J C
RJ
D015415:Biomarkers / Q000032:analysis; D023881:Colonography, Computed Tomographic; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*; D005243:Feces / Q000737:chemistry; D020022:Genetic Predisposition to Disease; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications; D008403:Mass Screening / Q000379:methods*; D009780:Occult Blood; D012307:Risk Factors; D012812:Sigmoidoscopy
D015415:Biomarkers